135 related articles for article (PubMed ID: 23806562)
1. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.
Zhu Q; Liu M; Dai L; Ying X; Ye H; Zhou Y; Han S; Zhang JY
Autoimmun Rev; 2013 Oct; 12(12):1123-8. PubMed ID: 23806562
[TBL] [Abstract][Full Text] [Related]
2. Immunoseroproteomic profiling in autoantibody to ENO1 as potential biomarker in immunodiagnosis of osteosarcoma by serological proteome analysis (SERPA) approach.
Li J; Dai L; Huang M; Ma Y; Guo Z; Wang X; Li W; Zhang JY
Oncoimmunology; 2021; 10(1):1966969. PubMed ID: 38260036
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.
Jacqueline C; Lee A; Frey N; Minden JS; Finn OJ
Cancer Immunol Res; 2020 Aug; 8(8):1027-1038. PubMed ID: 32467324
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer.
Cui C; Duan Y; Qiu C; Wang P; Sun G; Ye H; Dai L; Han Z; Song C; Wang K; Shi J; Zhang J
Front Oncol; 2021; 11():637871. PubMed ID: 33718231
[TBL] [Abstract][Full Text] [Related]
5. The identification of human tumour antigens: Current status and future developments.
Miles AK; Matharoo-Ball B; Li G; Ahmad M; Rees RC
Cancer Immunol Immunother; 2006 Aug; 55(8):996-1003. PubMed ID: 16408215
[TBL] [Abstract][Full Text] [Related]
6. An Immunoproteomic Survey of the Antibody Landscape: Insights and Opportunities Revealed by Serological Repertoire Profiling.
Ionov S; Lee J
Front Immunol; 2022; 13():832533. PubMed ID: 35178051
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.
Wang P; Song C; Xie W; Ye H; Wang K; Dai L; Zhang Y; Zhang J
J Immunol Res; 2014; 2014():512540. PubMed ID: 24822225
[TBL] [Abstract][Full Text] [Related]
8. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
Chen H; Werner S; Tao S; Zörnig I; Brenner H
Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
[TBL] [Abstract][Full Text] [Related]
9. A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma.
Li T; Xia J; Yun H; Sun G; Shen Y; Wang P; Shi J; Wang K; Yang H; Ye H
Cancer Cell Int; 2023 Nov; 23(1):273. PubMed ID: 37974212
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma.
Liu S; Liu W; Ding Z; Yang X; Jiang Y; Wu Y; Liu Y; Wu J
Front Mol Biosci; 2022; 9():912620. PubMed ID: 36339718
[No Abstract] [Full Text] [Related]
11. Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization.
Zhang J; Guo X; Jin B; Zhu Q
Front Oncol; 2022; 12():970623. PubMed ID: 35936692
[No Abstract] [Full Text] [Related]
12. Rapid, site-specific labeling of "off-the-shelf" and native serum autoantibodies with T cell-redirecting domains.
Zappala F; Higbee-Dempsey E; Jang B; Miller J; Yan L; Minutolo NG; Rosado González GT; Tsourkas A; Ozdemir BA
Sci Adv; 2022 May; 8(18):eabn4613. PubMed ID: 35522741
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging.
Cao X; Zhang Y; Zhou Q; Sun S; He M; Wang X; Ma P; Yang X; Lv L; Zhan L
Front Oncol; 2022; 12():794101. PubMed ID: 35251971
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of serum autoantibodies in children with B-cell acute lymphoblastic leukemia by serological proteome analysis.
Yu R; Yang S; Liu Y; Zhu Z
Proteome Sci; 2022 Feb; 20(1):3. PubMed ID: 35109855
[TBL] [Abstract][Full Text] [Related]
15. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
16. Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis.
Wang T; Huang XY; Zheng SJ; Liu YY; Chen SS; Ren F; Lu J; Duan ZP; Liu M
Front Oncol; 2021; 11():733680. PubMed ID: 34722278
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma.
Li J; Qin B; Huang M; Ma Y; Li D; Li W; Guo Z
Front Immunol; 2021; 12():665106. PubMed ID: 33995397
[TBL] [Abstract][Full Text] [Related]
18. CAR-T cells and BiTEs in solid tumors: challenges and perspectives.
Edeline J; Houot R; Marabelle A; Alcantara M
J Hematol Oncol; 2021 Apr; 14(1):65. PubMed ID: 33874996
[TBL] [Abstract][Full Text] [Related]
19. Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.
Shu X; Cao KY; Liu HQ; Yu L; Sun LX; Yang ZH; Wu CA; Ran YL
Stem Cell Res Ther; 2021 Feb; 12(1):119. PubMed ID: 33579362
[TBL] [Abstract][Full Text] [Related]
20. CAR T cells in solid tumors: challenges and opportunities.
Marofi F; Motavalli R; Safonov VA; Thangavelu L; Yumashev AV; Alexander M; Shomali N; Chartrand MS; Pathak Y; Jarahian M; Izadi S; Hassanzadeh A; Shirafkan N; Tahmasebi S; Khiavi FM
Stem Cell Res Ther; 2021 Jan; 12(1):81. PubMed ID: 33494834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
